Startups
Sequenta was acquired by Adaptive Biotechnologies (ow.ly/L8mCX) in January 2015. Visit adaptivebiotech.com or https://www.linkedin.com/company/adaptive-biotechnologies-corp- for the latest company news.
Sequenta was a venture-backed biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. The company, located in South San Francisco, was founded in 2008.
Sequenta was a venture-backed biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. The company, located in South San Francisco, was founded in 2008.
Overview
Location
United States, California, South San Francisco
Employees
51-200
Total raised
$20M
Founded date
2008
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 17, 2025 | Arima Genomics: $22 Million Series C Funding Closed And Tom Willis Named As CEO | Arima Genomics – a company utilizing whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights – announced the appointment of Tom Willis, PhD, as CEO and the closing of a $22 million Series C... |
| Jan 12, 2015 | Adaptive Biotechnologies Acquires Sequenta | Adaptive Biotechnologies Corporation, a Seattle, WA-based company that leverages next generation sequencing to profile T-cell and B-cell receptors, acquired Sequenta, Inc., a South San Francisco, California-based developer of clinical diagn... |
| Jan 7, 2015 | Adaptive Buys Sequenta to Disrupt Cancer Diagnosis, Drug Discovery | Twice in the past year, Adaptive Biotechnologies raised a truckload of cash. The first time, the company invested in its cutting-edge immune system sequencing. This time, it is using the loot to acquire a competitor, and hatch new plans to ... |
| Oct 20, 2014 | Sequenta Receives Equity Investment from Celgene | Sequenta, Inc., a South San Francisco, CA-based biotechnology company developing clinical diagnostics based on immune cell receptor genes, received an equity investment from Celgene Corporation and other strategic investors. This financing,... |
| Jul 2, 2013 | Sequenta Completes $20M in Series C | SOUTH SAN FRANCISCO, CA, Biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics, today announced the completion of a $20 million S... |
| Jul 2, 2013 | Sequenta Completes $20M Series C Financing | Sequenta, Inc., a South San Francisco, CA-based biotechnology company, completed a $20m Series C financing. The round was led by Foresite Capital Management, with participation from existing investors MDV and Index Ventures. In conjunction ... |
Reviews 0
FAQ about Sequenta, Inc.
When was Sequenta, Inc. founded?
Sequenta, Inc. was founded in 2008.
How much funding has Sequenta, Inc. raised?
Sequenta, Inc. has raised $20M in total across 1 funding round.
What has the press written about Sequenta, Inc.?
Parsers VC has collected 7 articles mentioning Sequenta, Inc., among them “Arima Genomics: $22 Million Series C Funding Closed And Tom Willis Named As CEO” (Jun 17, 2025) and “Adaptive Biotechnologies Acquires Sequenta” (Jan 12, 2015).
Is Sequenta, Inc. still active?
Yes, Sequenta, Inc. is active; its latest activity on Parsers VC dates from Jun 17, 2025.